Literature DB >> 22192664

The treatment of femoropopliteal in-stent restenosis: back to the future.

John R Laird, Khung Keong Yeo.   

Abstract

Mesh：

Year:  2012        PMID： 22192664     DOI： 10.1016/j.jacc.2011.09.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  Mechanical damage characterization in human femoropopliteal arteries of different ages.

Authors:  Eric Anttila; Daniel Balzani; Anastasia Desyatova; Paul Deegan; Jason MacTaggart; Alexey Kamenskiy
Journal:  Acta Biomater       Date:  2019-03-28       Impact factor: 8.947

2.  Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.

Authors:  Abhisekh Mohapatra; Zein Saadeddin; Daniel J Bertges; Michael C Madigan; Georges E Al-Khoury; Michel S Makaroun; Mohammad H Eslami
Journal:  J Vasc Surg       Date:  2019-08-10       Impact factor: 4.268

Review 3.  Nitinol Stents in the Femoropopliteal Artery: A Mechanical Perspective on Material, Design, and Performance.

Authors:  Kaspars Maleckis; Eric Anttila; Paul Aylward; William Poulson; Anastasia Desyatova; Jason MacTaggart; Alexey Kamenskiy
Journal:  Ann Biomed Eng       Date:  2018-02-22       Impact factor: 3.934

4.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

5.  The association between periprocedural factors and the late outcome of percutaneous stenting of lower extremity arteries. A retrospective cohort study.

Authors:  Paweł Grzelązka; Klaudia Koza; Adrianna Trofimiuk; Karol Suppan; Marcin Wasielewski; Joanna Wiśniewska; Jacek Budzyński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-06-22       Impact factor: 1.426

Review 6.  New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease.

Authors:  Jesse Naghi; Ethan A Yalvac; Ali Pourdjabbar; Lawrence Ang; John Bahadorani; Ryan R Reeves; Ehtisham Mahmud; Mitul Patel
Journal:  Med Devices (Auckl)       Date:  2016-06-28

7.  Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.

Authors:  Osamu Iida; Yoshimitsu Soga; Kazushi Urasawa; Shigeru Saito; Michael R Jaff; Hong Wang; Hiroko Ookubo; Hiroyoshi Yokoi
Journal:  J Endovasc Ther       Date:  2017-12-21       Impact factor: 3.487

8.  Comparison of morphometric, structural, mechanical, and physiologic characteristics of human superficial femoral and popliteal arteries.

Authors:  Majid Jadidi; Sayed Ahmadreza Razian; Eric Anttila; Tyler Doan; Josiah Adamson; Margarita Pipinos; Alexey Kamenskiy
Journal:  Acta Biomater       Date:  2020-11-21       Impact factor: 8.947

9.  Calcification patterns in femoral and carotid atheromatous plaques: A comparative morphometric study.

Authors:  Mircea Catalin Cosarca; Emőke Horváth; Calin Molnar; Gyopár-Beáta Molnár; Eliza Russu; Vasile Adrian Mureșan
Journal:  Exp Ther Med       Date:  2021-06-11       Impact factor: 2.447

10.  Feasibility and Clinical Outcomes of Peripheral Drug-Coated Balloon in High-Risk Patients with Femoropopliteal Disease.

Authors:  Shih-Jung Jang; Chien-An Hsieh; Hsuan-Li Huang; Jyh-Ming Jimmy Juang; Hsin-Hua Chou; Chueh-Yung Tsao; Tien-Yu Wu; Yu-Lin Ko
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.